Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00610636 | Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy | unknown | Phase 3 | 200 | National Taiwan University HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00601549 | A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT) | unknown | Phase 3 | 600 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 |
| clinicaltrials |
| NCT01320319 | Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients(EPA-colo) | unknown | Phase 2 / Phase 3 | 70 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | completed | Phase 2 / Phase 3 | 426 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 2, 2012 | clinicaltrials |
| NCT00385970 | A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer | unknown | Phase 3 | 380 | Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment GroupOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 430 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 86 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | terminated | Phase 2 / Phase 3 | 88 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 64 | Hoffmann-La RocheINDUSTRY | 3 | Sep 18, 2012 | clinicaltrials |
| NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00981110 | Standard Versus Advanced Antimicrobial Dressing Containing Ionic Silver Following Colorectal Cancer Surgery(AM) | completed | Phase 3 | 120 | European Institute of OncologyOTHER | 1 | Sep 11, 2012 | clinicaltrials |
| NCT01072851 | Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print | completed | Phase 3 | 920 | Trinity Health Of New EnglandOTHER | 1 | Sep 7, 2012 | clinicaltrials |
| NCT01251666 | Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening(HeMO) | completed | Phase 3 | 19,797 | University Hospital, CaenOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT00470951 | Randomized Prospective Trial for Laparoscopic vs Open Resection for Rectal Cancer(CTS-179) | unknown | Phase 3 | 340 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 10 | Aug 7, 2012 | clinicaltrials |
| NCT01653301 | Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study(INTERACT) | unknown | Phase 3 | 616 | Catholic University of the Sacred HeartOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 3 | 554 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 2, 2012 | clinicaltrials |
| NCT01609504 | ELRR by TEM Versus Laparoscopic TME in iT2N0M0 SMALL LOW RECTAL CANCER(ELRRvsLTME) | completed | Phase 3 | 283 | University of Roma La SapienzaOTHER | 0 | Jun 1, 2012 | clinicaltrials |
| NCT00006269 | Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer | terminated | Phase 3 | 89 | NovartisINDUSTRY | 1 | May 25, 2012 | clinicaltrials |
| NCT00268398 | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases(MIROX) | completed | Phase 3 | 284 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | May 22, 2012 | clinicaltrials |
| NCT01370928 | Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled Trial | completed | Phase 3 | 190 | Sorlandet Hospital HFOTHER_GOV | 1 | Apr 27, 2012 | clinicaltrials |
| NCT01579591 | VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer | unknown | Phase 3 | 160 | Catholic University of the Sacred HeartOTHER | 1 | Apr 18, 2012 | clinicaltrials |
| NCT01566942 | FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00137683 | Colorectal Cancer Control in Appalachian Churches | withdrawn | Phase 2 / Phase 3 | 0 | Centers for Disease Control and PreventionFED | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01064999 | A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | unknown | Phase 2 / Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | completed | Phase 3 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00208546 | Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer | completed | Phase 3 | 750 | Dutch Colorectal Cancer GroupOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00911391 | Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy | completed | Phase 3 | 85 | University of Auckland, New ZealandOTHER | 1 | Nov 29, 2011 | clinicaltrials |
| NCT01459328 | Resource-Sparing Curative Treatment for Rectal Cancer | unknown | Phase 3 | 350 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 25, 2011 | clinicaltrials |
| NCT01048463 | Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor | unknown | Phase 3 | 90 | Sun Yat-sen UniversityOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT00606983 | Prevention of Acute Voiding Difficulty After Radical Proctectomy | completed | Phase 3 | 100 | Seoul National University HospitalOTHER | 1 | Jul 20, 2011 | clinicaltrials |
| NCT01087268 | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer | unknown | Phase 3 | 75 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00152230 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | completed | Phase 3 | 900 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00145314 | FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer | completed | Phase 3 | 571 | The Nordic Colorectal Cancer Biomodulation GroupOTHER | 1 | Jan 14, 2011 | clinicaltrials |
| NCT00230646 | Promoting Physical Activity After Colorectal Cancer | completed | Phase 3 | 46 | The Miriam HospitalOTHER | 1 | Oct 5, 2010 | clinicaltrials |
| NCT01186081 | Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer | completed | Phase 3 | 240 | Asan Medical CenterOTHER | 1 | Aug 23, 2010 | clinicaltrials |
| NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | completed | Phase 3 | 330 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00209742 | Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer | unknown | Phase 3 | 340 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01130233 | Randomized Trial on Robotic Assisted Resection for Rectal Cancer | unknown | Phase 3 | 98 | The University of Hong KongOTHER | 1 | May 25, 2010 | clinicaltrials |
| NCT00738790 | Preoperative Radiotherapy and Local Excision in Rectal Cancer | unknown | Phase 3 | 102 | Polish Colorectal Cancer Study GroupNETWORK | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00833131 | The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer | unknown | Phase 3 | 540 | Polish Colorectal Cancer Study GroupNETWORK | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 102 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 1,302 | Eli Lilly and CompanyINDUSTRY | 17 | Apr 12, 2010 | clinicaltrials |
| NCT00425152 | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer | completed | Phase 3 | 2,151 | NSABP Foundation IncNETWORK | 0 | Feb 8, 2010 | clinicaltrials |
| NCT01060501 | Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer(FOGT1) | completed | Phase 3 | 796 | University of UlmOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 / Phase 3 | 600 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT00378716 | Combination Chemotherapy in Treating Patients With Resected Colon Cancer | completed | Phase 3 | 1,608 | NSABP Foundation IncNETWORK | 0 | Jan 11, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Dec 10, 2012source: clinicaltrials